Earkart IPO - AstroIPO

Earkart IPO


September 29, 2025 Written By Mihir Gohel, Reviewed and Fact Checked by Harpal Parmar

Earkart Ltd. is preparing for its healthcare sector entrance through its upcoming public debut. The Earkart IPO, scheduled from September 25th to September 29th, 2025, brings a ₹49.26 crore public issue of 36,49,000 shares at a fixed price of ₹135 per share.

Market participants can subscribe with a minimum of 2,000 shares, requiring ₹2,70,000 investment. The Earkart IPO shares, carrying ₹10 face value, will be listed on BSE, introducing this healthcare specialist to the public markets through a streamlined fixed-price offering structure in the medical sector.

Earkart IPO Details

The key details of Earkart’s IPO are outlined below, covering all crucial aspects from price range to investment requirements and regulatory documents.

IPO Size ₹49.26 Cr
Price Range ₹135
Retail Quota 50%
QIB Quota --
NII Quota 50%
Employee Discount --
Listing at BSE
Minimum Quantity 2,000
Investment (cut-off price) ₹2,70,000
Pre IPO Promotor Holding 78.75%
Post IPO Promotor Holding 57.34%
DHRP Draft Click Here
RHP Draft Click Here
Anchor Investors List Click Here

Earkart IPO Timelines

The IPO process for Earkart includes key dates for participants to know. The timeline allows for strategic planning and participation, helping investors stay informed and engaged throughout the entire process.

25/09/2025
Start Date
29/09/2025
End Date
30/09/2025
Allotment Date View Status
01/10/2025
Refund Initiation
01/10/2025
Credit of Shares to Demat Ac
03/10/2025
Listing Date

Earkart IPO Lot Size

The Earkart IPO has a fixed lot size of 1,000 shares, at a fixed price band of ₹135 per share. For retail investors, the minimum and maximum application is 2,000 shares (2 lots) amounting to ₹2,70,000. For HNI investors, the minimum application is 3,000 shares (3 lots), requiring an investment of ₹4,05,000.

Application Lot Size Shares Amount
Retail Minimum 2 2000 ₹2,70,000
Retail Maximum 2 2000 ₹2,70,000
HNI Minimum 3 3000 ₹4,05,000

Earkart IPO Subscription Status

The subscription status for Earkart IPO shows market demand across different investor categories, providing valuable insights into the offering’s performance. You can track real-time subscription data below.

QIB NII Retail EMP Total
-- 0.04x 0.04x -- 0.04x

IPO Performance on Listing Day

Opening Price Closing Price Day High Day Low

Earkart IPO Company Financials

Earkart reports robust performance in FY2025 with Total Income of ₹43.19 crores, managing expenses at ₹34.18 crores, and achieving a strong PAT (Profit After Tax) of ₹6.88 crores, demonstrating significant growth potential ahead of its public offering.

Year Total Income Total Expense PAT
FY 2023 ₹28.97 ₹27.51 ₹1.31
FY 2024 ₹31.97 ₹28.72 ₹3.06
FY 2025 ₹43.19 ₹34.18 ₹6.88

About Company

Earkart Limited is a HealthTech platform specializing in modern hearing aids and related accessories. The company offers a range of advanced hearing devices including Receiver In Canal, Invisible In The Canal, Behind The Ear, In The Ear, In The Canal, and Completely In Canal models. In addition to hearing aids, Earkart also distributes mobility and educational products such as adjustable foldable walkers, Multi Sensory Integrated Educational Development kits, and Teaching Learning Material for individuals with physical challenges. The company operates through a network of partners and clinics both in India and internationally and is a trusted supplier to the Government e-Marketplace, providing hearing aids to ALIMCO under the Ministry of Social Justice and Empowerment.

In April 2024, Earkart launched its Shop in Shop model, offering franchise opportunities to opticians and ENT or optical clinics. As of now, the company runs 49 such SIS clinics across 22 cities in six states and two Union Territories, including Haryana, Uttar Pradesh, Rajasthan, Punjab, Jharkhand, Delhi, Uttarakhand, and Chandigarh. Earkart’s manufacturing facility is based in Noida and spans an area of 4500 square feet, supporting its production and supply chain operations.

Incorporation Date Sector Managing Director
2021 Healthcare Rohit Misra

Know Before Investing

When evaluating Earkart's IPO potential, understanding both its market advantages and inherent risks becomes crucial for your investment. Below are the key insights you should consider.

Earkart IPO Strengths

  • Earkart operates in a fast-growing hearing aid industry in India, addressing the unmet needs of over 12 crore people with hearing problems.
  • Trusted supplier on the Government e-Marketplace (GeM) to entities like ALIMCO under the Ministry of Social Justice & Empowerment, contributing over 69% of product revenue.
  • Over 1,300 dealers across 181 locations across India, ensuring broad reach and customer access to hearing aids and audiology services.
  • Operating 49 SIS clinics across 22 cities, providing integrated audiometry diagnosis and hearing aid sales, with plans to expand to 200 clinics by FY26.
  • Focuses on delivering premium, Bluetooth-enabled, rechargeable hearing aids at affordable prices, bridging the affordability gap.
  • Demonstrated profitable operations with steady revenue growth since inception, selling approximately 20 hearing aids daily and planning rapid scale-up.

Earkart IPO Risks

  • Earkart relies on a network of domestic and international suppliers for raw materials and components required for manufacturing hearing aids. Any delays, disruptions, or quality issues can adversely affect operations and product quality.
  • Faces competition from various established and new players in the hearing aid manufacturing and distribution sector, which may limit market share and pricing power.
  • Prior delays in regulatory and statutory filings may attract penalties and negatively impact the company’s reputation and finances.
  • Quality issues in hearing aids can lead to order cancellations, loss of customer trust, and brand damage affecting sales and profitability.
  • The restated financial statements were prepared by peer-reviewed accountants rather than statutory auditors, potentially affecting auditing quality perceptions.
  • Future success depends on expanding the Sahaj distributor network, increasing clinic and audiometry presence, and scaling manufacturing which carry execution risks.

Swot Analysis for Earkart IPO

Understanding Earkart's SWOT analysis is your first step towards making a confident investment decision. Let's evaluate its core strengths and potential challenges ahead.

Strengths

Extensive Dealer Network, Strong Customer Support, Affordable Premium Products

Weaknesses

Limited In-House Manufacturing, Dependence on Dealer Partners, Geographical Concentration

Opportunities

Government Healthcare Initiatives, Rural and Tier 2/3 Market Penetration, Growing Awareness and Acceptance

Threats

Competition from Established Brands, Regulatory Challenges, Dependence on Import Supply Chain

Company Details

Earkart Ltd.

Shop No. 8-P, Street No. 6, Vasundhara Enclave, East Delhi, New Delhi, 110096

Phone: 0120-4102857

Email: cs@earkart.in

Website: https://www.earkart.in/

IPO Registar Details

Skyline Financial Services Pvt. Ltd.

Phone: 02228511022

Email: ipo@skylinerta.com

Website: https://www.skylinerta.com/ipo.php

FAQs

The key objectives of Earkart SME IPO are:

  • Funding incremental working capital requirements of the Company
  • Funding capital expenditure requirements for setting of Shop in Shop (SIS) Business Model in ENT/Ophthalmic Clinics across India and Setting up of Infrastructure for operational activities
  • General Corporate Purposes

Sarthi Capital Advisors Pvt. Ltd. is the book-running lead managers for the Earkart IPO.

Earkart IPO shows strong growth potential with revenue rising to ₹43.19 crore and profit after tax reaching ₹6.88 crore in FY25. Expanding government contracts and innovative retail models support future demand though competition, regulatory shifts, and reliance on government approvals pose key risks.

The issue price for the Earkart IPO is set to ₹135 per share.

To invest in two lot of Earkart IPO, you need ₹2,70,000 at the fixed price band (₹135 per share) for a lot size of 2000 shares.

Earkart IPO shares are scheduled to be listed on the Bombay Stock Exchange (BSE) on October 3, 2025.

Refund/unblocking of funds for Earkart IPO will begin on October 1, 2025. ASBA/UPI blocks will be removed within 1 working day.

You can sell shares your Earkart IPO shares on listing day (October 3, 2025) after they are credited to your demat account. If you want to sell in the pre-open market, the timing for that session is from 9:00 AM to 9:15 AM. Otherwise, you can sell after 10:00 AM during regular trading hours.

Leave a Reply

Your email address will not be published. Required fields are marked *